Publication Details
Abstract
Functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS), are significant challenges in modern medicine due to their prevalence and impact on quality of life. IBS affects approximately 10–20% of the global population and is often accompanied by anxiety-phobic disorders, which exacerbate the condition. This study aimed to identify the prevalence of anxiety-phobic disorders in patients with IBS and to evaluate the effectiveness of medical and psychological interventions. A cohort of 70 IBS patients aged 25–55 years was assessed at the Tashkent Medical Academy between 2022 and 2023. Diagnosis was based on clinical, laboratory, and psychological evaluations using the ZR Ibodullaev questionnaire and HADS scale. Treatment protocols included psychotherapy, cognitive therapy, and self-training. Anxiety levels were assessed at baseline and after treatment. Results indicated a significant prevalence of anxiety-phobic disorders among IBS patients, with psychoemotional symptoms contributing to maladaptation and reduced work capacity. After treatment, the main group showed a marked decrease in clinical anxiety (from 9 to 3 patients) and an increase in anxiety-free individuals (from 4 to 24 patients). In contrast, the control group exhibited a moderate improvement. The findings highlight the critical role of psychoemotional factors in IBS pathogenesis and demonstrate that integrating psychotherapy with standard IBS treatment can effectively alleviate anxiety-phobic symptoms. This approach not only improves the psychosocial well-being of patients but also enhances their overall quality of life. Future research should focus on optimizing treatment protocols to address the biopsychosocial nature of IBS.